CAR T-Cell Therapy Achieves Lasting Remission in Multiple Myeloma

Recent clinical trials have demonstrated unprecedented advances in the treatment of multiple myeloma with CAR T-cell therapy. This novel approach involves genetically modifying a patient's T-cells to be more effective at targeting and killing myeloma cells, promising long-term remission.
FOR MORE INFORMATION CLICK HERE ➖
https://www.edhacare.com/treatments/cancer/car-t-cell-therapy
Multiple myeloma is a cancer of the plasma cells that has been hard to treat traditionally, with relapses often occurring after standard therapies. CAR T-cell therapy, however, has shown a marked decrease in the populations of cancerous cells, and patients have entered into long periods of remission.